EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Chemical Epigenetics: Small Molecules Targeting Chromatin Modifiers in Disease Modulation

Benedict Nnachi Alum, Darlington Arinze Echegu, Esther Ugo Alum

Cell Biochemistry and Biophysics · 19.03.2026 · 84 (2) · 1875-1911

DOI: 10.1007/s12013-026-02049-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Biochemistry and Biophysics, online erschienen am 19.03.2026. Verfasst von Benedict Nnachi Alum und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Mathematics and Computing, Kampala International University, Kampala, Uganda. benedict.alum@kiu.ac.ug. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Chromatin, Small Molecule Libraries. Die Arbeit nennt 323 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Epigenetic regulation controls gene expression through reversible chromatin modifications, including DNA methylation, histone acetylation, methylation, phosphorylation, and ubiquitination. Dysregulation of these processes contributes to oncogenesis, neurodegeneration, and metabolic disorders. Small-molecule modulators of chromatin-modifying enzymes are emerging as powerful tools for understanding epigenetic mechanisms and developing targeted therapies. OBJECTIVE: This review aims to synthesize advances in chemical epigenetics by bridging medicinal chemistry, chemical biology, and translational medicine. It highlights the therapeutic relevance of small-molecule modulators, evaluates their clinical progress, and identifies future opportunities in precision medicine. METHODS: A narrative review approach was employed, integrating evidence from preclinical studies, clinical trials, and technological innovations. The analysis covers rational drug design strategies, such as orthosteric and allosteric inhibitors, proteolysis targeting chimeras (PROTAC)-mediated protein degradation, and dual-targeting approaches, alongside enabling technologies including chemoproteomics, activity-based probes, and CRISPR–dCas9 fusion systems. RESULTS: Epigenetic modulators have demonstrated clinical utility in oncology and show promise in neurology, immunology, and cardiometabolism. FDA-approved inhibitors such as vorinostat, azacytidine, and tazemetostat exemplify the therapeutic potential of targeting chromatin regulators. However, challenges persist, including context-specific effects, toxicity, and resistance. Strategies combining multi-omics profiling, and combinatorial therapies are reshaping the clinical trajectory of epigenetic drugs. Emerging frontiers include epitranscriptomics, artificial intelligence-assisted drug discovery, synthetic epigenetic circuits, and exploration of noncanonical functions of chromatin regulators. CONCLUSION: Chemical epigenetics represents both a mechanistic toolkit and a therapeutic framework for precision medicine. Advances beyond traditional methods of the chromatin-based interventions can transform the disease treatment regimen and enable the creation of more specific therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticChromatinSmall Molecule LibrariesHumansAnimalsProteolysis Targeting Chimera

Stichwörter der Autor:innen

Chemical epigeneticsChromatin modifiersEmerging therapiesPrecision medicineSmall-molecule modulators

Substanzen

ChromatinSmall Molecule LibrariesProteolysis Targeting Chimera

Autor:innen und Institutionen

  • School of Mathematics and Computing, Kampala International University, Kampala, Uganda. benedict.alum@kiu.ac.ug.
  • School of Mathematics and Computing, Kampala International University, Kampala, Uganda.
  • Research and Publication Department, Kampala International University, Kampala, Uganda. esther.alum@kiu.ac.ug.

Zitieren

APA

Alum, B. N., Echegu, D. A., & Alum, E. U. (2026). Chemical Epigenetics: Small Molecules Targeting Chromatin Modifiers in Disease Modulation. Cell Biochemistry and Biophysics, 84(2), 1875-1911. https://doi.org/10.1007/s12013-026-02049-5

Vancouver

Alum BN, Echegu DA, Alum EU. Chemical Epigenetics: Small Molecules Targeting Chromatin Modifiers in Disease Modulation. Cell Biochemistry and Biophysics. 2026;84(2):1875-1911. doi:10.1007/s12013-026-02049-5

BibTeX
@article{Alum2026,
  author = {Alum, Benedict Nnachi and Echegu, Darlington Arinze and Alum, Esther Ugo},
  title = {Chemical Epigenetics: Small Molecules Targeting Chromatin Modifiers in Disease Modulation},
  journal = {Cell Biochemistry and Biophysics},
  year = {2026},
  volume = {84},
  number = {2},
  pages = {1875--1911},
  doi = {10.1007/s12013-026-02049-5}
}
Kostenlos starten →